Published in Parkinsonism Relat Disord on April 20, 2013
Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience (2013) 1.20
Stimulating at the right time: phase-specific deep brain stimulation. Brain (2016) 0.81
Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments. J Neurol (2015) 0.79
Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing. J Neural Transm (Vienna) (2017) 0.79
Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y) (2014) 0.77
Approach to a tremor patient. Ann Indian Acad Neurol (2016) 0.75
Deep brain stimulation for the treatment of uncommon tremor syndromes. Expert Rev Neurother (2016) 0.75
Deep brain stimulation for myoclonus-dystonia syndrome with double mutations in DYT1 and DYT11. Sci Rep (2017) 0.75
Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression. Mov Disord (2011) 2.12
Computer-aided placement of deep brain stimulators: from planning to intraoperative guidance. IEEE Trans Med Imaging (2005) 1.99
Botulinum toxin type A therapy during pregnancy. Mov Disord (2004) 1.94
Renal impairment of pure autonomic failure. Hypertension (2009) 1.67
Potential subjects' responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson's disease. J Clin Ethics (2012) 1.61
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord (2005) 1.54
Accuracy of customized miniature stereotactic platforms. Stereotact Funct Neurosurg (2005) 1.46
CranialVault and its CRAVE tools: a clinical computer assistance system for deep brain stimulation (DBS) therapy. Med Image Anal (2010) 1.24
Effect of brain shift on the creation of functional atlases for deep brain stimulation surgery. Int J Comput Assist Radiol Surg (2009) 1.22
Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat Clin Pract Neurol (2008) 1.21
Optically mediated nerve stimulation: Identification of injury thresholds. Lasers Surg Med (2007) 1.19
ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int J Cancer (2003) 1.15
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target. Neurosurgery (2007) 1.11
Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry (2011) 1.08
The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurgery (2007) 1.07
Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther (2007) 1.06
Clinical accuracy of a customized stereotactic platform for deep brain stimulation after accounting for brain shift. Stereotact Funct Neurosurg (2010) 1.06
Validation of a fully automatic method for the routine selection of the anterior and posterior commissures in magnetic resonance images. Stereotact Funct Neurosurg (2009) 1.04
Intersurgeon variability in the selection of anterior and posterior commissures and its potential effects on target localization. Stereotact Funct Neurosurg (2008) 1.03
Automatic selection of DBS target points using multiple electrophysiological atlases. Med Image Comput Comput Assist Interv (2005) 1.02
Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor. BMC Neurol (2010) 1.01
Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes? Mov Disord (2006) 0.99
Delayed occurrence of multiple spinal drop metastases from a posterior fossa choroid plexus papilloma. Case report. J Neurosurg Spine (2006) 0.97
Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale. J Parkinsons Dis (2012) 0.97
The treatment of movement disorders by deep brain stimulation. Neurotherapeutics (2008) 0.96
Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg (2010) 0.94
Alteration of GABAergic neurotransmission by pulsed infrared laser stimulation. J Neurosci Methods (2010) 0.93
Deep brain stimulation of the subthalamic nucleus reduces antiparkinsonian medication costs. Parkinsonism Relat Disord (2004) 0.92
Timing and direction selectivity of subthalamic and pallidal neurons in patients with Parkinson disease. Exp Brain Res (2005) 0.91
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol (2011) 0.91
Deep brain stimulation for Parkinson's disease: the Vanderbilt University Medical Center experience, 1998-2004. Tenn Med (2007) 0.91
Prevalence of unilateral tremor in autosomal dominant essential tremor. Mov Disord (2009) 0.89
An infiltrative variant of non-neural granular cell tumor: a case report. J Cutan Pathol (2009) 0.88
Treating post-traumatic tremor with deep brain stimulation: report of five cases. Parkinsonism Relat Disord (2013) 0.88
Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism Relat Disord (2008) 0.88
Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg (2008) 0.87
Decreased Rate of CSF Leakage Associated with Complete Reconstruction of Suboccipital Cranial Defects. J Neurol Surg B Skull Base (2012) 0.86
Atypical junctional melanocytic proliferations in benign lichenoid keratosis. Hum Pathol (2003) 0.86
Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol (2012) 0.86
Neuronal coding of implicit emotion categories in the subcallosal cortex in patients with depression. Biol Psychiatry (2013) 0.86
Discordance in informed consent response on the basis of demographic factors: brief report. Intellect Dev Disabil (2010) 0.86
Effect of data normalization on the creation of neuro-probabilistic atlases. Stereotact Funct Neurosurg (2013) 0.85
Confined stimulation using dual thalamic deep brain stimulation leads rescues refractory essential tremor: report of three cases. Stereotact Funct Neurosurg (2009) 0.84
Linear measurements of the cerebral ventricles are correlated with adult ventricular volume. J Clin Neurosci (2013) 0.84
Lateral approach to a neurenteric cyst of the cervical spine: case presentation and review of surgical technique. Spine (Phila Pa 1976) (2003) 0.84
Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. Cancer Lett (2009) 0.83
FUS in familial essential tremor - the search for common causes is still on. Parkinsonism Relat Disord (2013) 0.83
Multimodality treatment of trigeminal neuralgia. Stereotact Funct Neurosurg (2006) 0.82
Neuro-oncological applications of optical spectroscopy. Technol Cancer Res Treat (2006) 0.82
Multisurgeon, multisite validation of a trajectory planning algorithm for deep brain stimulation procedures. IEEE Trans Biomed Eng (2014) 0.81
No increased herniation of the cerebellar tonsils in a group of patients with orthostatic intolerance. Clin Auton Res (2002) 0.81
A method to correct for brain shift when building electrophysiological atlases for deep brain stimulation (DBS) surgery. Med Image Comput Comput Assist Interv (2009) 0.81
Quantifying drug induced dyskinesia in Parkinson's disease patients using standardized videos. Conf Proc IEEE Eng Med Biol Soc (2008) 0.80
Difficulty in securing treatment for degenerative hip disease in a patient with Down syndrome: the gap remains open. J Natl Med Assoc (2006) 0.80
Epstein-Barr virus is not associated with angioleiomyomas, or other cutaneous smooth muscle tumors in immunocompetent individuals. J Cutan Pathol (2009) 0.80
Suppression of thalamocortical oscillations following traumatic brain injury in rats. J Neurosurg (2012) 0.80
Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease. Neurosurgery (2015) 0.79
60-Hz frequency effect on gait in Parkinson's disease with subthalamic nucleus deep brain stimulation. Neuromodulation (2013) 0.78
Pharmacological treatment of disabling tremor. Expert Opin Pharmacother (2005) 0.78
Clinical testing of an alternate method of inserting bone-implanted fiducial markers. Int J Comput Assist Radiol Surg (2014) 0.77
Imaging optically induced neural activity in the brain. Conf Proc IEEE Eng Med Biol Soc (2010) 0.77
Frontiers in the surgical treatment of Parkinson's disease. Expert Rev Neurother (2008) 0.77
Barriers to conducting research with community-dwelling adults who have intellectual disabilities. Intellect Dev Disabil (2011) 0.77
Neurologist consistency in interpreting information provided by an interactive visualization software for deep brain stimulation postoperative programming assistance. Neuromodulation (2013) 0.77
Ventricular width and complicated recovery following deep brain stimulation surgery. Stereotact Funct Neurosurg (2012) 0.77
Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. Mov Disord (2010) 0.77
Positive family history of essential tremor influences the motor phenotype of Parkinson's disease. Mov Disord (2009) 0.76
Deep brain stimulation for early-stage Parkinson's disease: an illustrative case. Neuromodulation (2011) 0.76
Deep brain stimulation: a new treatment for Parkinson's disease. Tenn Med (2003) 0.76